Issue Date: June 1, 2009
On The Map
IN 2002, executives from a small drug company in South Africa flew to Paris on what they feared was a futile mission. The Aspen Pharmacare team arrived at the doorstep of Bristol-Myers Squibb (BMS), the maker of several HIV drugs, with their caps in one hand and a videocassette of an HIV clinic in the Eastern Cape, near the birthplace of Nelson Mandela, in the other. Their message was simple: Your . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society